Drawing for Serial No. 79347162

USPTO serial 79347162

Serial No. 79347162

Reviewed by CopyMark Law Group

Reg. 7147556Status 700Registered
Filing date
Status date
Registration date
Aug 29, 2023
Examiner
ANKRAH, NAAKWAMA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79347162?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa M. Melanson

Lisa M. Melanson McCarthy Tétrault LLP745 Thurlow Streetc/o Suite 2400Vancouver, BC, V6E0C5

Goods and services

ClassDescriptionStatusFirst use
036Charitable fundraising; Charitable fundraising services to raise awareness of and improve care for hemophilia and other bleeding disorders in Canada and throughout the worldACTIVE—
041Publishing research, namely scientific papers, providing general information and conducting conferences on subjects of interest to hemophiliacs and people with bleeding disordersACTIVE—
044Charitable services in the nature of providing medical care supplies to non-profit organizations dedicated to improving care for hemophilia and other bleeding disorders in Canada and throughout the world; charitable services in the nature of providing medical care and health care services dedicated to improving care for hemophilia and other bleeding disorders in Canada and throughout the world; charitable services in the nature of providing medical care supplies to international non-profit organizations dedicated to introducing, improving and monitoring care for people with hemophilia and inherited bleeding disorders around the world; charitable services in the nature of providing medical care and health care services dedicated to introducing, improving and monitoring care for people with hemophilia and inherited bleeding disorders around the worldACTIVE—
045Political lobbying services, namely, lobbying governments for improved health care to hemophiliacs and people with bleeding disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 26, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 4, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 4, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 29, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 29, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 29, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 13, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 13, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 24, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 24, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 10, 2023XAECEXAMINER'S AMENDMENT ENTERED—
May 10, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 10, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
May 10, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2023XAECEXAMINER'S AMENDMENT ENTERED—
May 9, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 9, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
May 9, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
May 4, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 14, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 20, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2023DOCKASSIGNED TO EXAMINER—
Aug 16, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 12, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 11, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance